Symbol: |
RAP2B
|
Description: |
RAP2B, member of RAS oncogene family [Source:HGNC Symbol;Acc:9862]
|
Location: |
Chr3:152880029-152886265[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:306
Gene |
Compound |
Gen_sig |
Exp_pattern |
RAP2B |
Naphtho[2,3-d]thiazole-4,9-dione, 2-[(4-nitrophenyl) amino]- |
0.026 |
Down |
RAP2B |
L-Lysine, N-[(methylamino)carbonyl]-N'-(phenylmethoxy- carbonyl)-, phenylmethyl ester |
0.015 |
Down |
RAP2B |
Disulfide, bis[2-amino-4-(4-methoxyphenyl)-1-methyl- 1H-imidazol-5-yl], dihydrochloride |
0.032 |
Down |
RAP2B |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.011 |
Down |
RAP2B |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride |
0.034 |
Down |
RAP2B |
NSC 641594 |
0.005 |
Down |
RAP2B |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.021 |
Down |
RAP2B |
NSC 645364 |
0.01 |
Down |
RAP2B |
4-Methylthio-N-(3,4,5-trimethoxybenzyl)aniline |
0.036 |
Down |
RAP2B |
NSC 651650 |
0.003 |
Down |
RAP2B |
NSC 652536 |
0.01 |
Down |
RAP2B |
NSC 655266 |
0.045 |
Down |
RAP2B |
ANTINEOPLASTIC-655905 |
0.013 |
Down |
RAP2B |
NSC 656208 |
0.046 |
Down |
RAP2B |
NSC 656210 |
0.015 |
Down |
Expression pattern: Sensitivity / Resistance
Total:21 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:82
Total:6 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:1
Gene |
Gen_transcript |
miRNA |
miR_location |
RAP2B |
ENST00000323534 |
hsa-mir-138-1-3p |
Chr3:44155766-44155787[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|